---
title: "Cytisinicline in Smoking cessation: References"
description: "Reference list for the formulary evidence report on Cytisinicline in Smoking cessation. 83 cited documents."
canonical: "https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/references"
published: "2026-09-14T15:39:06-04:00"
modified: "2026-11-17T19:46:25-05:00"
---

# Cytisinicline in Smoking cessation: References

<a id="references"></a>

## 5 References

1. [Achieve Life Sciences](https://achievelifesciences.com/products/)
2. [Achieve Life Sciences (2022)](https://ir.achievelifesciences.com/news-events/press-releases/detail/141/achieve-life-sciences-announces-successful-statistically-significant-smoking-cessation-results-in-phase-3-orca-2-clinical-trial-of-cytisinicline-in-adult-smokers)
3. [Achieve Life Sciences (2023)](https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0000950170-23-023533/0000950170-23-023533.pdf)
4. [Achieve Life Sciences 52-week safety data announcement (2026)](https://ir.achievelifesciences.com/news-events/press-releases/detail/262/achieve-life-sciences-presents-safety-data-from-52-weeks-of-continuous-cytisinicline-treatment)
5. [Achieve Life Sciences complete response letter announcement (2026)](https://ir.achievelifesciences.com/news-events/press-releases/detail/264/achieve-life-sciences-receives-complete-response-letter-from-fda-for-cytisinicline-nda)
6. [Achieve Life Sciences Expanded Access Policy](https://achievelifesciences.com/products/expanded-access-policy/)
7. [Achieve Life Sciences NDA acceptance announcement (2025)](https://ir.achievelifesciences.com/news-events/press-releases/detail/238/achieve-life-sciences-announces-fda-acceptance-of-cytisinicline-new-drug-application-for-treatment-of-nicotine-dependence-for-smoking-cessation)
8. [Achieve Life Sciences ORCA-1](https://achievelifesciences.com/products/phase-2-orca-1-trial/)
9. [Achieve Life Sciences ORCA-2](https://achievelifesciences.com/products/phase-3-orca-2-trial/)
10. [Achieve Life Sciences ORCA-3](https://achievelifesciences.com/products/phase-3-orca-3-trial/)
11. [Achieve Life Sciences public offering pricing announcement (2025)](https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0000950170-25-091055/achv-ex99_2.htm)
12. [Achieve Life Sciences second quarter 2025 results announcement (2025)](https://achievelifesciences.com/achieve-announces-2q25-financial-results/)
13. [Achieve Life Sciences second quarter 2026 results announcement (2026)](https://ir.achievelifesciences.com/news-events/press-releases/detail/268/achieve-life-sciences-reports-second-quarter-2026-financial-results-and-provides-business-updates)
14. [Achieve Life Sciences SRNT ORCA-OL data announcement (2026)](https://achievelifesciences.com/achieve-presents-orca-ol-data-at-srnt/)
15. [Achieve Life Sciences third quarter 2026 results announcement (2026)](https://ir.achieverx.com/news-events/press-releases/detail/277/achieverx-reports-third-quarter-2026-financial-results-and-provides-business-updates)
16. [Achieve Life Sciences Thorax publication announcement (2025)](https://achievelifesciences.com/achieve-announces-thorax-publication-of-cytisiniclines-potential-efficacy-and-tollerability-for-smoking-cessation-in-individuals-with-copd/)
17. [Agaku (2026)](https://pubmed.ncbi.nlm.nih.gov/41805408/)
18. [Anraad et al. (2018)](https://pubmed.ncbi.nlm.nih.gov/29430762/)
19. [Bektaş Aksoy (2026)](https://www.tobaccoinduceddiseases.org/Real-world-effectiveness-of-cytisine-bupropion-and-nicotine-nreplacement-therapy%2C217961%2C0%2C2.html)
20. [Bonteque Consulting Ltd. patient information leaflet (2025)](https://www.medicines.org.uk/emc/files/pil.15789.pdf)
21. [Bonteque Consulting Ltd. Summary of Product Characteristics (2025)](https://www.medicines.org.uk/emc/product/15789/smpc)
22. [Cani et al. (2026)](https://doi.org/10.1016/j.jtho.2026.104071)
23. [CDC Cigarette Smoking](https://www.cdc.gov/tobacco/about/index.html)
24. [CDC Economic Trends in Tobacco (2024)](https://www.cdc.gov/tobacco/php/data-statistics/economic-trends/index.html)
25. [CDC Tips From Former Smokers withdrawal symptoms](https://www.cdc.gov/tobacco/campaign/tips/quit-smoking/7-common-withdrawal-symptoms/index.html)
26. [Courtney et al. (2021)](https://pmc.ncbi.nlm.nih.gov/articles/PMC8261608/)
27. [De Santi et al. (2024)](https://pubmed.ncbi.nlm.nih.gov/38161271/)
28. [Dizon et al. (2026)](https://ascopubs.org/doi/10.1200/JCO.2026.44.16_suppl.e22676)
29. [Dogar et al. (2020)](https://pubmed.ncbi.nlm.nih.gov/33069301/)
30. [eCQI Resource Center CMS138v14 (2026)](https://ecqi.healthit.gov/sites/default/files/ecqm/measures/CMS138-v14.0.000-QDM.html)
31. [Hajek et al. (2013)](https://pubmed.ncbi.nlm.nih.gov/23404838/)
32. [ICER (2026)](https://icer.org/news-insights/press-releases/institute-for-clinical-and-economic-review-publishes-final-evidence-report-on-medication-for-smoking-cessation/)
33. [ICER final evidence report (2026)](https://icer.org/wp-content/uploads/2026/02/ICER_Smoking-Cessation_Final-Report_For-Publication_021226.pdf)
34. [Jacobs et al. (2023)](https://pubmed.ncbi.nlm.nih.gov/36198104/)
35. [Jeong et al. (2015)](https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/dta.1707)
36. [Jeong et al. (2018)](https://pubmed.ncbi.nlm.nih.gov/29168931/)
37. [Jeong et al. (2019)](https://pubmed.ncbi.nlm.nih.gov/30526213/)
38. [Jiménez-Ruiz et al. (2023)](https://pubmed.ncbi.nlm.nih.gov/36549936/)
39. [Leaviss et al. (2014)](https://pubmed.ncbi.nlm.nih.gov/24831822/)
40. [Li et al. (2022)](https://bmjopen.bmj.com/content/12/8/e049644)
41. [Lindson et al. (2023)](https://doi.org/10.1002/14651858.CD015226.pub2)
42. [Livingstone-Banks et al. (2023)](https://www.cochrane.org/evidence/CD006103_can-medications-varenicline-and-cytisine-nicotine-receptor-partial-agonists-help-people-stop-smoking)
43. [MedChemExpress (2025)](https://file.medchemexpress.com/batch_PDF/HY-N0175/Cytisinicline-SDS-MedChemExpress.pdf)
44. [Mir et al. (2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12399143/)
45. [Mussio et al. (2026)](https://bmjopen.bmj.com/content/16/2/e113050)
46. [New York State Department of Health](https://talktoyourpatients.health.ny.gov/nicotine-addiction)
47. [NICE Evidence Review Q (2025)](https://www.ncbi.nlm.nih.gov/books/NBK613971/)
48. [Nides et al. (2021)](https://pmc.ncbi.nlm.nih.gov/articles/PMC8403245/)
49. [Nikitin et al. (2026)](https://pubmed.ncbi.nlm.nih.gov/42166301/)
50. [Oreskovic et al. (2023)](https://pubmed.ncbi.nlm.nih.gov/37291049/)
51. [Pastorino et al. (2022)](https://pubmed.ncbi.nlm.nih.gov/35908731/)
52. [Phusahat et al. (2022)](https://pmc.ncbi.nlm.nih.gov/articles/PMC9603285/)
53. [Piper et al. (2012)](https://pmc.ncbi.nlm.nih.gov/articles/PMC3298628/)
54. [Prochaska et al. (2026)](https://pubmed.ncbi.nlm.nih.gov/40962497/)
55. [Puljević et al. (2024)](https://onlinelibrary.wiley.com/doi/10.1111/add.16592)
56. [Rábade Castedo et al. (2026)](https://www.researchprotocols.org/2026/1/e76815)
57. [Rábade-Castedo et al. (2023)](https://pubmed.ncbi.nlm.nih.gov/37567792/)
58. [Reddy et al. (2024)](https://jamanetwork.com/journals/jama-health-forum/fullarticle/2822687)
59. [Rigotti and Benowitz (2026b)](https://www.tandfonline.com/doi/full/10.1080/14656566.2026.2646283)
60. [Rigotti et al. (2023)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10336611/)
61. [Rigotti et al. (2024)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11074928/)
62. [Rigotti et al. (2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12012700/)
63. [Rigotti et al. (2026a)](https://achievelifesciences.com/wp-content/uploads/2026/03/ALS28399-SRNT-2026_Oral_Prior-treatment_v2.11_3Mar26.pdf)
64. [Rigotti et al. (2026c)](https://achievelifesciences.com/wp-content/uploads/2026/05/ATS_2026_ORCA-OL.pdf)
65. [Rubinstein and Jacobs (2026b)](https://pubmed.ncbi.nlm.nih.gov/41885134/)
66. [Rubinstein et al. (2026a)](https://achievelifesciences.com/wp-content/uploads/2026/03/ALS28801_26_SRNT_Exit-Interview_Poster_2March2026.pdf)
67. [Rubinstein et al. (2026c)](https://jheor.org/article/160017-comparative-effectiveness-of-cytisinicline-and-varenicline-for-smoking-cessation-a-matching-adjusted-indirect-comparison-maic)
68. [Rubinstein et al. (2026d)](https://achievelifesciences.com/wp-content/uploads/2026/05/ATS_2026_MAIC.pdf)
69. [Rungruanghiranya et al. (2024)](https://onlinelibrary.wiley.com/doi/10.1111/resp.14787)
70. [Siddiqi et al. (2024)](https://pubmed.ncbi.nlm.nih.gov/38321591/)
71. [Tedesco et al. (2025a)](https://link.springer.com/article/10.1007/s11739-025-03888-5)
72. [Tedesco et al. (2025b)](https://link.springer.com/article/10.1007/s11739-025-04067-2)
73. [Tinghino et al. (2024)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11129281/)
74. [Tutka et al. (2019)](https://pubmed.ncbi.nlm.nih.gov/31240783/)
75. [U.S. Department of Health and Human Services (2020)](https://www.ncbi.nlm.nih.gov/books/NBK555593/)
76. [USPSTF (2021)](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions)
77. [VanFrank et al. (2024)](https://www.cdc.gov/mmwr/volumes/73/wr/mm7329a1.htm)
78. [Vinnikov et al. (2008)](https://www.cambridge.org/core/journals/journal-of-smoking-cessation/article/abs/doubleblind-randomised-placebocontrolled-trial-of-cytisine-for-smoking-cessation-in-mediumdependent-workers/FD545EF13935E1F029600D6D1BC8A3DD)
79. [Walker et al. (2014)](https://www.asat.org.ar/images/comunidad/publicaciones/cistisina.pdf)
80. [Walker et al. (2021)](https://onlinelibrary.wiley.com/doi/10.1111/add.15489)
81. [West et al. (2011)](https://pubmed.ncbi.nlm.nih.gov/21991893/)
82. [WHO (2024)](https://www.who.int/news/item/02-07-2024-who-releases-first-ever-clinical-treatment-guideline-for-tobacco-cessation-in-adults)
83. [WHO Expert Committee (2025)](https://list.essentialmeds.org/recommendations/1472)

## Related pages
- [Cytisinicline: Smoking cessation](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation) · [Markdown](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation.md)
- [Cytisinicline in Smoking cessation: Terms and abbreviations](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/terms-and-abbreviations.md)
- [Cytisinicline: Smoking cessation](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/executive-summary) · [Markdown](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/executive-summary.md)
- [Cytisinicline in Smoking cessation: Product information and disease description](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/product-information-and-disease-description.md)
- [Cytisinicline in Smoking cessation: Clinical evidence](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/clinical-evidence.md)
- [Cytisinicline in Smoking cessation: Economic information and modeling report](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/economics) · [Markdown](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/economics.md)
- [Cytisinicline in Smoking cessation: prevalence by geography](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/prevalence) · [Markdown](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/prevalence.md)
- [Cytisinicline in Smoking cessation: cost-effectiveness analyses and utility weights](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/cost-effectiveness-analyses) · [Markdown](https://www.evicenter.com/drugs/cytisinicline--smoking-cessation/cost-effectiveness-analyses.md)
